D.A.L. Morgan

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

Harry Bartelink, P. Maingon, Philip Poortmans et al. · The Lancet Oncology · 2014 · 669 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +9

The prognostic significance of lymphovascular invasion in invasive breast carcinoma

Emad A. Rakha, Stewart G. Martin, Andrew H.S. Lee et al. · Cancer · 2011 · 255 citations · Full text

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

Sandra Collette, Laurence Collette, Tom Budiharto et al. · European Journal of Cancer · 2008 · 223 citations

Surgical Oncology, Breast Oncology, Cancer Epidemiology +10

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

R.W. Blamey, T Bates, U Chetty et al. · European Journal of Cancer · 2013 · 220 citations

Ii Trial, Radiation Medicine, Surgical Oncology +11

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999

R.W. Blamey, Ian O. Ellis, S Pinder et al. · European Journal of Cancer · 2007 · 201 citations

Breast Oncology, Cancer Epidemiology, Invasive Breast Cancer +9